Replies to post #35194 on Revive Therapeutics Ltd (RVVTF)

[tripmcneely]

Yes and the PR is a written response to the public regarding said written responses from the GDA where RVVTF said no thanks we will ignore and continue with previous end points which were already rejected by the FDA.

Hospitalizations and deaths are no longer a thing to 99%+ of the public with these weaker strains. Hence why FDA wants time to resolved symptoms.

Does this drug help people who get sick with covid get better faster yes or no? That’s it. Thats what the FDA wants to know. Not whether they will die.

The FDA is looking for essentially a stronger Dayquil for covid. Plain and simple.

Revive is ignoring that request apparently. Or the data doesn’t support it. That simple

[Ecomike]

Indeed:

As recently reported by the Company, the FDA has granted the Company’s Type C meeting request to obtain agreement on the revised protocol endpoints for the Company’s Phase 3 clinical trial (the “Study”) (NCT04504734) to evaluate the safety and efficacy of bucillamine, an oral drug with anti-inflammatory and antiviral properties, in patients with mild to moderate COVID-19. The goal date for the FDA to provide its written responses is March 7, 2023.

TYPE C Meeting..............When requesting a Type C meeting, Sponsors can request a written response to their questions rather than an in-person meeting, videoconference, or teleconference. A sponsor may request a face-to-face meeting, but the FDA may decide that only a written response is necessary.



Yes, written correspondence would equate to a "back and forth" between parties.

Some should learn to Read and Comprehend before posting laughably mindless comments. lololsss

[White chocolate 250]

Really? So fda said we want these endpoints and mf said nope we are good with the old ones? That doesn’t sound much like a back and forth to agree on endpoints. That is the fda saying we will accept these endpoints and mf, in all his brilliance, saying no I feel like screwing everyone and wasting the past year so I will stick with the old ones. I’m sure you will have an excuse for that as well. Just make sure you buy all the shares in the next dilution to fund the rest of the trial that has no patients. It takes some sort of idiot not to unblind a trial that you know you can’t finish. At this point he is just dragging this thing out. Unblind and sell based on the pcr data and maybe they can salvage a couple hundred mill.

[govprs]

No one is questioning the back and forth which is a positive

It’s all up to MF to make good decisions on how to spend the millions he raised 3x the pps today

He’s not very smart according to the pps and the staggering losses by many bag holders here